Brochure
10 Sep 2025
Revolutionizing Enzymes for Diagnostic and Biopharma Industries
PDF 187 kB
At Novonesis, we specialize in creating novelrecombinant enzymes tailored to the requiredtechnical parameters, all at scalable prices
Content provided by our supplier
Novonesis
-
Country/Region:Denmark
-
On CPHI since:2025
-
Certificates:1
-
Employees:5000+
Company types
Primary activities
Other Content from Novonesis (1)
-
Brochure Embrace biosolutions today for a sustainable and competitive tomorrow
From concept to commercialization, Novonesis recombinant enzymes for fine chemicals provide a renewable and cost-efficient alternative to replace chemicals, metals, and solvents to improve processes cost-effectively by use of sustainable alternatives to chemicals for better quality APIs and intermediates. Partner with us to drive innovation in Pharma, diagnostics, cell culture, peptides, and regenerative medicine.